Centre for Personalised Therapeutics Technologies

Abstract submission for the 2024 MPS World Summit in Seattle, Washington is now open. The deadline for submission is fast approaching Friday, December 15 at 11:59 PM PT. mpsworldsummit.com/2024-abstract-… #mpsworldsummit2024 #mpsworldsummit #microphysiologicalsystems

@ARC_CPTT director, Alastair Stewart was among the 103 experts from 66 organisations @CSIRO spoke to for its new report assessing the potential of emerging non-animal models to complement traditional animal research approaches over the next 15 years. csiro.au/nonanimalmodels

Congratulations to the 2023 GCI Proof-of-Concept Funding Scheme Winners! clarkinstitute.unimelb.edu.au/news/congratul…

👉Innovate to Grow: Advanced Manufacturing-CSIRO Applications are open for a free 10-week program for small to medium enterprises working on advanced manufacturing solutions and exploring how research and development can advance their project or business. csiro.au/advancedmanufa…

Please join us for the research seminar from A/Prof. Dr Kate Poole (The University of New South Wales): “A Cellular Sense of Touch: Mechanically Activated Ion Channels” We hope to see many of you at this seminar. #arccptt

International MPS Society News: mailchi.mp/mail51.jh.edu/…

Welcome to Fiona Milner @epichem to @ARC_CPTT Industry Advisory Board! therapeutics-technologies.com.au/2023/05/23/wel…

This is a good read for everyone wanting to improve their writing skills. @EMCR_MIPS @YildizTasdan @CCeMMP @ARC_CTET @ARC_CPTT

The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory table clarkinstitute.unimelb.edu.au/news/the-fda-m…

MCN: an essential infrastructure and services to drive ARC CPTT innovation therapeutics-technologies.com.au/2023/03/23/mcn…

Join the Global MPS Day- Free Virtual Symposium on March 9, 2023. An event hosted by Emulate to celebrate the recent passing of the FDA Modernization Act 2.0 and discuss recent advancements in drug discovery and development with MPS. go.emulatebio.com/global-mps-day…

Our editorial “The FDA modernisation act 2.0: bringing non-animal technologies to the regulatory table” is now available online therapeutics-technologies.com.au/2023/01/31/our…

The FDA modernisation act 2.0 was passed in late 2022 enabling drug registration without animal studies and bringing microphysiological systems (MPS) to the regulatory table. To read more about the future regulatory role of MPS: authors.elsevier.com/a/1gWAC4r9Rknb… #fda #arccptt #mps

🔔 🔔 🔔 2nd MPS World Summit (June 26-30, 2023_Berlin, Germany) 📢 Abstract Submission Deadline Approaching - January 31 Travel Awards are available. Early Bird Registration until March 31. More information can be found here: mpsworldsummit.com/?ct=t%28EMAIL_…

👉MPS World Summit Newsletter: mailchi.mp/mail51.jh.edu/…

Applications for our 2023 program are now open! Want to know what it's like to take part in the BridgeTech Program? Read about Elizabeth Clarke's experience: bit.ly/Elizabeth-Clar… @KollingINST @MTPConnect_AUS #medtech #research

It’s amazing what ARC CPTT has achieved this year thanks to everyone working together! Looking forward to a New Year of successes with you. In the meantime, we wish you and your family a wonderful holiday season and a Happy New Year!

CPTT member, Dr Richard Lipscombe (MD, Proteomics International) presented the exciting commercialisation journey of PromarkerD for early detection of diabetic kidney disease. #arccptt

Prof Emeritus Daniel Hoyer, Former Head & Chair of Pharmacology and Therapeutics, University of Melbourne and former Director at Novartis presented on collaboration between Pharma and Academia.

Great overview from CPTT partners on IP management (Dr Daniel Beck,Senior Associate, Wrays),Innovation and the regulatory path (Dr Shreyas Dighe,Consultant,BioIntelect) and Data insights to drive innovations (Dr Hozana Castillo, Regional Solutions Consultant, Clarivate Analytics)